SALT LAKE CITY--(BUSINESS WIRE)--BSD Medical Corp. (NASDAQ:BSDM) today reported on the evolving clinical role of hyperthermia that was presented at the annual European Society for Hyperthermic Oncology (ESHO) Meeting, which was held in Verona, Italy on June 4 to June 6, 2009. The 25th annual ESHO meeting was held in conjunction with the 18th annual European BSD Users Meeting. The meeting title was “Improving Cancer Care in the 21st Century.” The object of the ESHO meeting was to review recent developments in the field of oncologic hyperthermia.
